June 2025 - Page 12 of 16

MondayJun 09, 2025 10:20 am

QualityStocksNewsBreaks – Nicola Mining Inc. (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) Secures Multi-Year Exploration Permit for Treasure Mountain Silver Project

Nicola Mining (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) has received a multi-year area-based exploration permit (MX-15-121) for its wholly owned Treasure Mountain Silver Project in British Columbia, complementing the previously granted 10-year mining lease extension under Permit M-239. The new MYAB Permit authorizes extensive exploration activities, including 30 drill holes, trenching, trail building, and geophysical surveys over the next five years. CEO Peter Espig said the combined permits position Nicola to advance both mining and exploration, leveraging strong silver prices to revitalize a historically significant asset. To view the full interview, visit https://ibn.fm/zz8dQ About Nicola Mining Nicola Mining Inc. is…

MondayJun 09, 2025 10:05 am

QualityStocksNewsBreaks – Next10, Inc., (OTC PINK: NXTN) Acquires Torreon Group to Expand Real Estate and Commercial Portfolio

Next10, Inc. (OTC PINK: NXTN) announced the acquisition of Arizona-based Torreon Group, a company with a robust portfolio in real estate development, commercial ventures, and strategic acquisitions. The deal marks a significant step in Next10’s growth strategy, with additional details to be released in upcoming announcements later this week. To view the full press release, visit https://ibn.fm/lLlr3 About QualityStocks QualityStocks (“QS”) is a specialized communications platform with a focus on private and public companies and the investment community. It is one of 70+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach…

MondayJun 09, 2025 9:00 am

QualityStocksNewsBreaks – Nutriband Inc. (NASDAQ: NTRB) Secures U.S. Patent for Abuse-Deterrent Transdermal Technology

Nutriband (NASDAQ: NTRB) has been granted U.S. patent No. 12,318,492 for its "Abuse and Misuse Deterrent Transdermal Systems," further strengthening domestic protection for its Aversa(TM) technology. The patent, issued June 3, 2025, enhances the company’s intellectual property portfolio for abuse-deterrent transdermal products designed to curb misuse, diversion, and accidental exposure. Aversa(TM) is currently in development as part of Nutriband’s lead product, Aversa Fentanyl, which aims to be the first abuse-deterrent fentanyl patch on the market, with peak U.S. sales potential projected between $80 million and $200 million. To view the full article, visit https://ibn.fm/BGFEy About Nutriband Inc. Nutriband is primarily…

FridayJun 06, 2025 3:47 pm

QualityStocksNewsBreaks – Newton Golf Company Inc. (NASDAQ: NWTG) Leads with Vision and Cutting-Edge Gear Amid Golf’s Resurgence

Newton Golf Company (NASDAQ: NWTG) is riding the wave of golf’s renewed popularity, driven by increasing diversity, inclusivity, and innovation within the sport. With more than 47 million Americans engaging in golf activities in 2024, the sport has evolved into a dynamic, accessible pastime. Newton Golf is capitalizing on this momentum by developing performance-enhancing products, including those in its Newton Motion Shaft and Gravity Putter lines, showcased at the 2025 PGA Show. The company’s strategic focus combines cutting-edge technology and community engagement, with products designed to optimize swing dynamics, improve putting accuracy and enhance performance and enjoyment for golfers of all…

FridayJun 06, 2025 3:16 pm

QualityStocksNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Positioning at the Center of Critical Materials, Innovation

Platinum Group Metals (NYSE American: PLG) (TSX: PTM) is strategically positioning itself for growth amid strong palladium market dynamics, driven by constrained supply and continued industrial demand. With palladium essential in automotive, electronics, and emerging clean energy applications, the company is advancing the Waterberg Project in South Africa—one of the largest undeveloped primary palladium and platinum projects globally. In partnership with Anglo American Platinum Limited, PLG is also investing in future-focused innovation through Lion Battery Technologies, which explores the use of platinum and palladium in next-generation lithium battery technologies. Among the few companies combining traditional mining development with tech-driven diversification, Platinum…

FridayJun 06, 2025 1:55 pm

QualityStocksNewsBreaks – Why Intelligent Bio Solutions Inc. (NASDAQ: INBS) Is ‘One to Watch’

Intelligent Bio Solutions (NASDAQ: INBS) is a medical technology company pioneering rapid, non-invasive diagnostics through its proprietary Intelligent Fingerprinting Drug Screening System. INBS was featured in a recent article that reads, “By utilizing fingerprint sweat analysis, the company offers a cost-effective, hygienic solution to detect recent drug use — targeting substances commonly found in workplace settings… The company’s vision is to redefine drug screening by removing the pain points of traditional testing methods, including biohazardous waste, privacy concerns, and long result turnaround times. With results in under 10 minutes and no need for gender-specific collectors or laboratory facilities, the system empowers…

FridayJun 06, 2025 12:45 pm

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Stands Out in Booming Gold Market, Offers Strategic Investment Avenue

The gold market's current dynamics underscore the metal's enduring appeal Lahontan Gold boasts a portfolio of four gold and silver projects located in Nevada's prolific Walker Lane LGCXF’s management team comprises seasoned professionals with extensive experience in mineral exploration, project development and corporate finance LGCXF recently named as “one of the best gold developers in Nevada” In an era marked by economic volatility and geopolitical tensions, gold has reasserted itself as a premier safe-haven asset. Gold prices have soared to unprecedented levels, surpassing $3,400 per ounce, driven by factors such as trade disputes, inflationary pressures and global uncertainty (https://ibn.fm/1Z7sV). This bullish…

FridayJun 06, 2025 12:00 pm

Intelligent Bio Solutions Inc. (NASDAQ: INBS) Showcases Portable Drug Testing System at RISE25 as U.S. Expansion Advances

The company’s non-invasive fingerprint drug screening system uses fingerprint sweat to screen for drugs such as cannabis, cocaine, methamphetamine, and opiates. Results are available in under ten minutes, supporting faster, on-site decision-making in treatment and justice settings. INBS is pursuing FDA approval and further entry into the U.S. market, where it currently operates in a Forensic Use Only capacity. The company has over 450 active accounts in 24 countries, targeting sectors such as healthcare, justice, and workplace safety. INBS partnered with SMARTOX, a U.S. distributor, to connect with stakeholders in criminal justice and addiction recovery. Intelligent Bio Solutions (NASDAQ: INBS),…

FridayJun 06, 2025 11:15 am

ESGold Corp. (CSE: ESAU) (OTCQB: ESAUF) Tests Potential for Streamlining Tailings Process, Offering Important Cost and Environment Benefits

ESGold is a gold and silver company preparing for production later this year at a tailings reclamation site in Quebec abandoned by the previous operator The gold and silver resource developer expects to concentrate on reprocessing the tailings for the near-term to extract mica and any remaining gold and silver, anticipating that the resulting mica concentrate will be useful in a wide variety of building and roadwork materials ESGold plans to build revenue through the reuse project, which can then help fund planned exploration at its Quebec property covering 13,116 hectares (about 32,410 acres) The company is currently conducting testing…

FridayJun 06, 2025 10:30 am

Soligenix Inc. (NASDAQ: SNGX) Offers Hope on the Horizon with HyBryte(TM) Treatment Targeting CTCL

Soligenix’s HyBryte(TM) is a photodynamic therapy using synthetically manufactured hypericin, one of the most photoactive compounds available. The therapeutic potential of HyBryte(TM) has been demonstrated through multiple clinical trials, including a Phase 3 trial in early-stage CTCL patients. HyBryte(TM) has been granted Orphan Drug Designation by the U.S. Food and Drug Administration and the European Medicines Agency. Cutaneous T-cell lymphoma (“CTCL”) is a rare and debilitating form of non-Hodgkin’s lymphoma that primarily affects the skin, posing both physical and emotional challenges for those diagnosed. With limited treatment options available and no definitive cure, the need for innovative, safe and effective…

Site Search

Company Search

Month: June 2025